<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.0.0 (http://www.squarespace.com/) on Tue, 06 Jan 2009 23:16:33 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>Negative &amp; Failed Clinical Trial Reports</title><link>http://brainscienceblogs.com/negative-failed-clinical-tria/</link><description></description><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.0.0 (http://www.squarespace.com/)</generator><item><title>Negative &amp; Failed Clinical Trial Reports</title><category>Negative &amp; Failed Clinical Trial Reports</category><dc:creator>Contacts</dc:creator><pubDate>Tue, 25 Mar 2008 21:45:10 +0000</pubDate><link>http://brainscienceblogs.com/negative-failed-clinical-tria/2008/3/25/negative-failed-clinical-trial-reports.html</link><guid isPermaLink="false">140403:2122225:1714342</guid><description><![CDATA[<p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">An Open-Label Study of Tiagabine in Panic Disorder<br />By David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD,and Juris Janavs, MD</a></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial<br />By Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD, <br />and Ramy A. Mahmoud, MD, MPH </a><br /></p>
]]></description><wfw:commentRss>http://brainscienceblogs.com/negative-failed-clinical-tria/rss-comments-entry-1714342.xml</wfw:commentRss></item></channel></rss>